VALN (Valneva SE) Net Margin % : -69.86% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Valneva SE Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Valneva SE's Net Income for the three months ended in Dec. 2024 was $-38.7 Mil. Valneva SE's Revenue for the three months ended in Dec. 2024 was $55.4 Mil. Therefore, Valneva SE's net margin for the quarter that ended in Dec. 2024 was -69.86%.

The historical rank and industry rank for Valneva SE's Net Margin % or its related term are showing as below:

VALN' s Net Margin % Range Over the Past 10 Years
Min: -65.99 Med: -23.7 Max: 2.89
Current: -7.22

VALN's Net Margin % is ranked better than
70.77% of 999 companies
in the Biotechnology industry
Industry Median: -131.37 vs VALN: -7.22

Valneva SE Net Margin % Historical Data

The historical data trend for Valneva SE's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Net Margin % Chart

Valneva SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Margin %

Get a 7-Day Free Trial

-58.37

-21.09

-39.66

-65.99

-7.22

Valneva SE Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Margin %	Get a 7-Day Free Trial															-76.75	179.86	-65.51	-20.16	-69.86

Competitive Comparison of Valneva SE's Net Margin %

For the Biotechnology subindustry, Valneva SE's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valneva SE's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Net Margin % distribution charts can be found below:

* The bar in red indicates where Valneva SE's Net Margin % falls into.

Save Embed

;

Save Embed

;

Valneva SE Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Valneva SE's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-12.824	/	177.569
	=	-7.22 %

Valneva SE's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-38.73	/	55.436
	=	-69.86 %

Valneva SE (NAS:VALN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Valneva SE Net Margin % Related Terms

Thank you for viewing the detailed overview of Valneva SE's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (NAS:VALN) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

INRLF:USA 0OB3:UK VLA:France AYJ:Germany VLA:Austria

Address

6 Rue Alain Bombard, Saint-Herblain, FRA, 44800

Website

https://www.valneva.com

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.